Bimekizumab Clinical Efficacy in Important Body Regions and Health-related Quality of Life in Patients with Plaque Psoriasis: Data from Four Phase 3/3b Comparator-controlled Trial Periods
Main Article Content
Keywords
psoriasis, bimekizumab, quality of life, scalp, nail, palmoplantar, high-impact areas, clinical trial, efficacy
Abstract
References
1. Timotijević ZS et al. Acta Dermatovenerol Croat 2017;25:215–22
2. Strober B et al. J Dermatolog Treat 2024;35:2287401
3. Augustin M & Radtke MA. Expert Rev Pharmacoecon Outcomes Res 2014;14:559–68
4. Reich K et al. Lancet 2021;397:487–98, NCT03370133
5. Gordon KB et al. Lancet 2021;397:475–86, NCT03410992
6. Warren RB et al. N Engl J Med 2021;385:130–41, NCT03412747
7. Reich K et al. N Engl J Med 2021;385:142–52, NCT03536884
2. Strober B et al. J Dermatolog Treat 2024;35:2287401
3. Augustin M & Radtke MA. Expert Rev Pharmacoecon Outcomes Res 2014;14:559–68
4. Reich K et al. Lancet 2021;397:487–98, NCT03370133
5. Gordon KB et al. Lancet 2021;397:475–86, NCT03410992
6. Warren RB et al. N Engl J Med 2021;385:130–41, NCT03412747
7. Reich K et al. N Engl J Med 2021;385:142–52, NCT03536884